These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38543240)

  • 1. CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy.
    Park H; Kang YK; Shim G
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review.
    Liu B; Wang Z; Gu M; Wang J; Tan J
    Transl Lung Cancer Res; 2024 Aug; 13(8):2067-2081. PubMed ID: 39263032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
    Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
    J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy.
    Xu Y; Chen C; Guo Y; Hu S; Sun Z
    Front Immunol; 2022; 13():848327. PubMed ID: 35300341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 applications in T cells and adoptive T cell therapies.
    Chen X; Zhong S; Zhan Y; Zhang X
    Cell Mol Biol Lett; 2024 Apr; 29(1):52. PubMed ID: 38609863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.
    Ou X; Ma Q; Yin W; Ma X; He Z
    Front Cell Dev Biol; 2021; 9():674467. PubMed ID: 34095145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment.
    Tong LW; Hu YS; Yu SJ; Li CL; Shao JW
    Nanotechnology; 2024 Jul; 35(40):. PubMed ID: 38964289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing.
    Cai W; Wang M
    Sci Bull (Beijing); 2019 Dec; 64(24):1841-1849. PubMed ID: 36659580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
    Ren J; Zhao Y
    Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
    Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA
    Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling immune checkpoint regulation: exploring the power of
    Wang Y; Khalil A; Kamar A; Du M; Dinh T; McFarland C; Wang Z
    Front Genet; 2023; 14():1304425. PubMed ID: 38162677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy.
    Afolabi LO; Afolabi MO; Sani MM; Okunowo WO; Yan D; Chen L; Zhang Y; Wan X
    Clin Transl Immunology; 2021; 10(6):e1286. PubMed ID: 34188916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
    Wu HY; Cao CY
    Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
    Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
    Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.
    Chen C; Wang Z; Qin Y
    Exp Hematol Oncol; 2023 Nov; 12(1):95. PubMed ID: 37964355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.